STAT+: Ultragenyx cuts staff after another study fails

Ultragenyx announced that it's laying off about 20% of its staff as it ends development of two rare disease drugs.

Reported by STAT. We will add other newspapers as they cover it. November 4, 2026, 14:46 UTC

How the newspaper covers this story

1. STATUnited StatesNovember 4, 2026, 14:46 UTC

   STAT+: Ultragenyx cuts staff after another study fails

   Ultragenyx announced that it's laying off about 20% of its staff as it ends development of two rare disease drugs.

   Read at STATRead translated